Cel-Sci Corporation NYSE American
Open: $4.85 High: $4.85 Low: $4.46 Close: $4.555
Range: 2022-06-27 - 2022-06-28
Market: Extended-hours
Cel-Sci Corporation 8229 BOONE BLVD .
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
  • CEO: Geert R. Kersten
  • Employees: 44
  • Sector: Healthcare
  • Industry: Biotechnology
Latest Stocks Posts
Card image
Card image
Card image
CVM News
Latest news about the CVM